PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+3.74%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$108M
AUM Growth
+$108M
(-16%)
Cap. Flow
-$23.4M
Cap. Flow
% of AUM
-21.68%
Top 10 Holdings %
Top 10 Hldgs %
47.95%
Holding
90
New
24
Increased
6
Reduced
15
Closed
22
Top Buys
| 1 |
Merck
MRK
|
$5.45M |
| 2 |
Edwards Lifesciences
EW
|
$3.49M |
| 3 |
SIEN
Sientra, Inc.
SIEN
|
$2.84M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$2.8M |
| 5 |
DexCom
DXCM
|
$2.75M |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
$6.09M |
| 2 |
HCA Healthcare
HCA
|
$3.95M |
| 3 |
Boston Scientific
BSX
|
$3.89M |
| 4 |
Hologic
HOLX
|
$3.85M |
| 5 |
ATHN
Athenahealth, Inc.
ATHN
|
$3.58M |
Sector Composition
| 1 | Healthcare | 81.28% |
| 2 | Industrials | 3.31% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ICU Medical
ICUI
$3.15B
| $7.07M | 4.17% | 28,000 -7,000 | -20% | -$1.77M |
|
2
Globus Medical
GMED
$8.27B
| $6.73M | 3.97% | 135,000 -47,500 | -26% | -$2.37M |
|
3
LivaNova
LIVN
$3.08B
| $6.38M | 3.77% | 72,100 -17,900 | -20% | -$1.58M |
|
|
4
Merck
MRK
$210B
| $5.45M | 3.22% | +100,000 | New | +$5.45M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.02M | 2.96% | 45,000 +25,100 | +126% | +$2.8M |
|
6
Baxter International
BAX
$12.7B
| $4.88M | 2.88% | 75,000 +5,000 | +7% | +$325K |
|
|
IVC
7
DELISTED
Invacare Corporation
IVC
| $4.82M | 2.85% | 276,796 -478 | -0.2% | -$8.32K |
|
|
XENT
8
DELISTED
Intersect ENT, Inc
XENT
| $4.32M | 2.55% | 110,000 +10,000 | +10% | +$393K |
|
9
Abbott
ABT
$231B
| $3.63M | 2.14% | 60,500 -19,500 | -24% | -$1.17M |
|
|
ATHN
10
DELISTED
Athenahealth, Inc.
ATHN
| $3.58M | 2.11% | 25,000 -25,000 | -50% | -$3.58M |
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.54M | 2.09% | 43,700 | – | – |
|
|
12
Edwards Lifesciences
EW
$47.8B
| $3.49M | 2.06% | +25,000 | New | +$3.49M |
|
13
Medtronic
MDT
$119B
| $3.41M | 2.01% | 42,500 +5,000 | +13% | +$401K |
|
|
SIEN
14
DELISTED
Sientra, Inc.
SIEN
| $2.84M | 1.68% | +294,172 | New | +$2.84M |
|
|
15
DexCom
DXCM
$29.5B
| $2.75M | 1.63% | +37,140 | New | +$2.75M |
|
|
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
| $2.71M | 1.6% | 422,000 +60,000 | +17% | +$386K |
|
17
Qiagen
QGEN
$10.1B
| $2.42M | 1.43% | +75,000 | New | +$2.42M |
|
|
18
Boston Scientific
BSX
$156B
| $2.39M | 1.41% | 87,500 -142,500 | -62% | -$3.89M |
|
19
United Therapeutics
UTHR
$13.8B
| $2.25M | 1.33% | 20,000 -909 | -4% | -$102K |
|
20
Rigel Pharmaceuticals
RIGL
$697M
| $2.07M | 1.22% | 584,563 -20,000 | -3% | -$70.8K |
|
|
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
| $2.01M | 1.19% | 50,268 -80,000 | -61% | -$3.2M |
|
|
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.98M | 1.17% | 50,000 +22,017 | +79% | +$870K |
|
|
NTUS
23
DELISTED
Natus Medical Inc
NTUS
| $1.94M | 1.15% | +57,620 | New | +$1.94M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $1.68M | 0.99% | +10,000 | New | +$1.68M |
|
25
Amicus Therapeutics
FOLD
$2.34B
| $1.5M | 0.89% | +100,000 | New | +$1.5M |
|